Okay, let's tackle this question about the best inotrope for right heart failure. First, I need to recall what inotropes are and how they work. Inotropes affect the force of heart contractions. For right heart failure, the right ventricle isn't pumping effectively, so we need an inotrope that can improve contractility without causing too much vasoconstriction, which might increase afterload.

The options aren't listed, but common inotropes include dobutamine, dopamine, milrinone, and epinephrine. Let's think about each. Dobutamine is a beta-1 agonist, which increases contractility but might also increase heart rate. Dopamine at low doses increases renal perfusion, but higher doses can cause vasoconstriction. Milrinone is a phosphodiesterase inhibitor, which causes both inotropic and vasodilatory effects. That's important because vasodilation reduces afterload, which is good for the right ventricle. Epinephrine is a strong alpha and beta agonist, which can increase afterload, making it less ideal.

So, right heart failure often requires reducing afterload. Milrinone's dual action of increasing contractility and dilating veins and arteries would be beneficial. Dobutamine might increase contractility but could also increase heart rate and possibly afterload if there's vasoconstriction. Dopamine's vasoconstrictive effects at higher doses would be bad. Epinephrine's alpha effects would constrict vessels, worsening afterload.

Therefore, the best choice is milrinone. The answer would be the option corresponding to milrinone. The other options are incorrect because they either increase afterload or have less favorable effects on the right ventricle.

**Core Concept**
Inotropic agents enhance myocardial contractility, but their utility in right heart failure depends on minimizing afterload. Right ventricular function is highly sensitive to pulmonary vascular resistance (PVR) and systemic vascular resistance (SVR), requiring agents that improve contractility while reducing afterload.

**Why the Correct Answer is Right**
Milrinone, a phosphodiesterase-3 inhibitor, increases intracellular cAMP in cardiac myocytes, enhancing calcium influx and contractility. It also causes vasodilation of systemic and pulmonary vessels, reducing both SVR and PVR. This dual action is critical in right heart failure, where elevated afterload (e.g., from pulmonary hypertension) impairs right ventricular ejection. By lowering afterload and improving contractility, milrinone optimizes right ventricular function without exacerbating volume overload.

**Why Each Wrong Option is Incorrect**
**Option A:** Dobutamine (beta-1 agonist) increases contractility but may raise heart rate and SVR, worsening right ventricular afterload. **Option B:** Dopamine at high doses activates alpha-1 receptors, causing vasoconstriction and increasing afterload. **Option C:** Epinephrine’s alpha-agonist effects dominate at higher doses, leading to systemic vasoconstriction and elevated afterload. **Option D:** Inhaled nitric oxide selectively dilates pulmonary vessels but lacks inotropic effects, making it insufficient for right ventricular support.

**Clinical Pearl / High-Yield Fact**
Milrinone is first-line for right heart failure secondary to pulmonary hypertension due to

✓ Correct Answer: D. Milrinone